These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [New treatment option for gram-positive infections in critically ill patients - overview over linezolid]. Krueger WA; Unertl KE Anasthesiol Intensivmed Notfallmed Schmerzther; 2002 Apr; 37(4):199-204. PubMed ID: 11967745 [TBL] [Abstract][Full Text] [Related]
12. Vancomycin-resistant enterococci. Rubinstein E; Keynan Y Crit Care Clin; 2013 Oct; 29(4):841-52. PubMed ID: 24094380 [TBL] [Abstract][Full Text] [Related]
13. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops. Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560 [TBL] [Abstract][Full Text] [Related]
14. Intrinsically vancomycin-resistant gram-positive organisms: clinical relevance and implications for infection control. Nelson RR J Hosp Infect; 1999 Aug; 42(4):275-82. PubMed ID: 10467540 [TBL] [Abstract][Full Text] [Related]
15. Considerations in the choice and administration of agents for empiric antimicrobial therapy. Baughman RP Surg Infect (Larchmt); 2005; 6 Suppl 2():S-71-82. PubMed ID: 23577498 [TBL] [Abstract][Full Text] [Related]
16. Management of the febrile neutropenic patient. Picazo JJ; Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492 [TBL] [Abstract][Full Text] [Related]